Functional micro-RNA drugs acting as a fate manipulator in the regulation of osteoblastic death

Zhengwen Cai1,2, Fengshuo Liu1, Yong Li1,2

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China. sirongshi@scu.edu.cn.

Nanoscale
|July 24, 2023
PubMed

Insights

Regulated cell death (RCD) influences bone diseases like osteoporosis. A novel tetrahedral DNA nanostructure (TDN) delivers microRNAs (miRNAs) to target RCD pathways, offering a promising therapeutic strategy for bone loss.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Nanotechnology

Background:

  • Bone loss, exemplified by osteoporosis, involves impaired osteoblast function, increased osteoclast activity, and disrupted bone homeostasis.
  • Current treatments for bone diseases are limited, highlighting the need for innovative therapeutic approaches.
  • Regulated cell death (RCD) pathways are implicated in bone diseases, suggesting that modulating osteoblast fate could be a viable treatment strategy.

Purpose of the Study:

  • To explore the role of microRNA (miRNA) networks in regulating key RCD programs (apoptosis, autophagy, pyroptosis, ferroptosis) within bone tissues.
  • To introduce a novel self-assembling tetrahedral DNA nanostructure (TDN)-based microRNA (Tmi) delivery system for enhanced miRNA therapy.
  • To provide insights into the clinical translation of miRNA-based therapies for bone diseases.

Main Methods:

  • Investigated the impact of the miRNA network on four critical RCD programs in bone.
  • Developed and characterized a tetrahedral DNA nanostructure (TDN) for microRNA (miRNA) delivery (Tmi system).
  • Evaluated the potential of the Tmi system for protecting miRNAs and facilitating intracellular transport to regulate RCD pathways.

Main Results:

  • miRNA networks significantly influence the initiation and progression of apoptosis, autophagy, pyroptosis, and ferroptosis in bone.
  • The TDN-based Tmi system demonstrates excellent biocompatibility, cell penetration, and stability for miRNA delivery.
  • The Tmi system effectively releases miRNAs intracellularly to modulate RCD signaling pathways.

Conclusions:

  • miRNA targeting via the Tmi delivery system offers a promising strategy for treating bone diseases characterized by abnormal RCD.
  • The TDN platform provides a versatile and effective vector for miRNA nucleic acid drugs, overcoming limitations of current delivery methods.
  • This approach holds potential for advancing the clinical application of miRNA therapeutics in bone regenerative medicine and disease treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
944
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K